These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. Kotzin BL, Palmer E. J Exp Med; 1987 May 01; 165(5):1237-51. PubMed ID: 3494806 [Abstract] [Full Text] [Related]
6. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice. Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA. Arthritis Rheum; 2012 Apr 01; 64(4):1237-46. PubMed ID: 22006377 [Abstract] [Full Text] [Related]
7. Idiotype restriction in murine lupus; high frequency of three public idiotypes on serum IgG in nephritic NZB/NZW F1 mice. Hahn BH, Ebling FM. J Immunol; 1987 Apr 01; 138(7):2110-8. PubMed ID: 3559204 [Abstract] [Full Text] [Related]
8. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice. Okudaira H, Terada E, Okudaira K. Prog Clin Biol Res; 1987 Apr 01; 229():157-74. PubMed ID: 3601985 [Abstract] [Full Text] [Related]
9. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Bynoté KK, Hackenberg JM, Korach KS, Lubahn DB, Lane PH, Gould KA. Genes Immun; 2008 Mar 01; 9(2):137-52. PubMed ID: 18200028 [Abstract] [Full Text] [Related]
10. Immunological studies concerning the nephritis of systemic lupus erythematosus. Koffler D, Schur PH, Kunkel HG. J Exp Med; 1967 Oct 01; 126(4):607-24. PubMed ID: 4168098 [Abstract] [Full Text] [Related]
11. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE. Lab Invest; 1993 Apr 01; 68(4):419-26. PubMed ID: 8479150 [Abstract] [Full Text] [Related]
17. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Arthritis Rheum; 2006 Mar 01; 54(3):914-26. PubMed ID: 16508974 [Abstract] [Full Text] [Related]
19. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model. Zhang M, Yu G, Chan B, Pearson JT, Rathanaswami P, Delaney J, Ching Lim A, Babcook J, Hsu H, Gavin MA. Arthritis Rheumatol; 2015 Oct 01; 67(10):2723-31. PubMed ID: 26097207 [Abstract] [Full Text] [Related]
20. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease. Fournie GJ, Minh MG, Mignon-Conte MA, Hass S, Lambert PH, Conte JJ. J Clin Lab Immunol; 1980 Sep 01; 4(2):103-6. PubMed ID: 7441709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]